Aripiprazole (aripiprazole oral) NDC 17856-0684

NDC codes

FDA NDC Directory

Product NDC (as listed)17856-0684Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17856-0684Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17856-0684-1	17856068401	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0684-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0684-3)Marketed from Jan 29, 2025
17856-0684-2	17856068402	72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0684-2) / 10 mL in 1 CUP, UNIT-DOSE (17856-0684-4)Marketed from Jan 29, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aripiprazole
Generic name (nonproprietary): aripiprazole oral
Active ingredients: Aripiprazole — 1 mg/mL
Dosage form: Solution
Route: Oral
Labeler: ATLANTIC BIOLOGICALS CORP.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216150
Marketing start: Nov 1, 2023
Listing expires: Dec 31, 2027
Identifiers: Product ID 17856-0684_56433edd-6668-ea4e-e063-6294a90aa48eSPL ID 56433edd-6668-ea4e-e063-6294a90aa48eSPL set ID 042b725c-1c17-4cfb-80b2-c841226d795eRxCUI 485496UNII 82VFR53I78
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417856068401 followed by a unit qualifier and the quantity

Package 17856-0684-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 10, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Aripiprazole oral solution is indicated for the treatment of: • Schizophrenia [see Clinical Studies (14.1) ] • Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder [see Clinical Studies (14.2) ] • Irritability Associated with Autistic Disorder [see Clinical Studies (14.4) ] • Treatment of Tourette’s Disorder [see Clinical Studies (14.5) ] Aripiprazole oral solution is an atypical antipsychotic. The oral formulations are indicated for: • Schizophrenia (14.1) • Acute Treatment of Manic and Mixed Episodes associated with Bipolar I (14.2) • Irritability Associated with Autistic Disorder (14.4) • Treatment of Tourette’s disorder (14.5)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216150

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216150
Product	Strength	Form · route	Labeler	Product NDC
Aripiprazolearipiprazole oral	Aripiprazole 1 mg/mL	SolutionOral	NorthStar RxLLC	72603-445
Aripiprazolearipiprazole oral	Aripiprazole 1 mg/mL	SolutionOral	Camber Pharmaceuticals, Inc.	31722-684